INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2019

Circulating but not fecal short-chain fatty acids were linked to insulin sensitivity, lipolysis, and GLP-1 concentrations in humans.

In a cross-sectional study of 160 participants, researchers examined associations of fecal and fasting circulating short-chain fatty acids (SCFA) with metabolic markers, including insulin sensitivity measured via hyperinsulinemic-euglycemic clamp in a subgroup of 93. Fasting circulating acetate, propionate, and butyrate were positively associated with fasting GLP-1. Circulating SCFA were negatively associated with whole-body lipolysis (glycerol: std β adj -0.190, P = 0.023), triacylglycerols (std β adj -0.202, P = 0.010), and free fatty acids (std β adj -0.306, P = 0.001). Circulating acetate was negatively correlated with insulin sensitivity (M-value: std β adj -0.294, P < 0.001), whereas propionate was positively correlated (std β adj 0.161, P = 0.033).

Shows an association, not proof of cause and effect.

Study type
Cross-sectional study
Who was studied
160 participants (64% male, BMI 19.2-41.0 kg/m2, normal or impaired glucose metabolism)
What was measured
Circulating metabolites, substrate oxidation, GLP-1 concentrations, and insulin sensitivity

THE PAPER

Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans.

Müller M, Hernández MAG, Goossens GH, Reijnders D, Holst JJ, Jocken JWE, van Eijk H, Canfora EE, Blaak EE. Sci Rep, 2019.

PubMed 31467327 ↗DOI 10.1007/bf00280883 ↗

Diabetes & blood sugarGut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.